We found that ectopic expression of TNC in pancreatic cancer cells resulted in downregulation of the epithelial marker E-cadherin and concomitant downregulation of the mesenchymal markers N-cadherin and Vimentin, whereas SP600125 significantly reversed the TNC-induced change in EMT markers. The gene discussed is CDH2; the disease is familial pancreatic carcinoma.